IRIS Accounts Production v25.2.0.378 05024705 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false A Ordinary 1.00000 B Ordinary 1.00000 7338 7338 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh050247052024-03-31050247052025-03-31050247052024-04-012025-03-31050247052023-03-31050247052023-04-012024-03-31050247052024-03-3105024705ns15:EnglandWales2024-04-012025-03-3105024705ns14:PoundSterling2024-04-012025-03-3105024705ns10:Director12024-04-012025-03-3105024705ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3105024705ns10:SmallEntities2024-04-012025-03-3105024705ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3105024705ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3105024705ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3105024705ns10:FullAccounts2024-04-012025-03-3105024705ns10:OrdinaryShareClass22024-04-012025-03-3105024705ns10:OrdinaryShareClass32024-04-012025-03-310502470542ns10:Director22024-04-012025-03-310502470542ns10:Director22025-03-3105024705ns10:Director22024-04-012025-03-3105024705ns10:CompanySecretary12024-04-012025-03-3105024705ns10:RegisteredOffice2024-04-012025-03-3105024705ns5:CurrentFinancialInstruments2025-03-3105024705ns5:CurrentFinancialInstruments2024-03-3105024705ns5:ShareCapital2025-03-3105024705ns5:ShareCapital2024-03-3105024705ns5:RetainedEarningsAccumulatedLosses2025-03-3105024705ns5:RetainedEarningsAccumulatedLosses2024-03-3105024705ns5:MotorVehicles2024-04-012025-03-3105024705ns5:ComputerEquipment2024-04-012025-03-3105024705ns5:MotorVehicles2024-03-3105024705ns5:ComputerEquipment2024-03-3105024705ns5:MotorVehicles2025-03-3105024705ns5:ComputerEquipment2025-03-3105024705ns5:MotorVehicles2024-03-3105024705ns5:ComputerEquipment2024-03-3105024705ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3105024705ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3105024705ns5:DeferredTaxation2024-03-3105024705ns5:DeferredTaxation2024-04-012025-03-3105024705ns5:DeferredTaxation2025-03-3105024705ns10:OrdinaryShareClass22025-03-3105024705ns10:OrdinaryShareClass32025-03-3105024705ns10:Director112024-03-3105024705ns10:Director112023-03-3105024705ns10:Director112024-04-012025-03-3105024705ns10:Director112023-04-012024-03-3105024705ns10:Director112025-03-3105024705ns10:Director112024-03-31
REGISTERED NUMBER: 05024705 (England and Wales)















Financial Statements for the Year Ended 31 March 2025

for

Dr Memon Dermatology Services Limited

Dr Memon Dermatology Services Limited (Registered number: 05024705)

Contents of the Financial Statements
for the Year Ended 31 March 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Dr Memon Dermatology Services Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: A A Memon
J Memon





SECRETARY: J Memon





REGISTERED OFFICE: Suites 5 & 6 The Printworks
Hey Road
Barrow
Clitheroe
Lancashire
BB7 9WB





REGISTERED NUMBER: 05024705 (England and Wales)





ACCOUNTANTS: Bennett Kirkhope Smith
Chartered Certified Accountants
Suites 5 & 6 The Printworks
Hey Road
Barrow
Clitheroe
Lancashire
BB7 9WB

Dr Memon Dermatology Services Limited (Registered number: 05024705)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 85,063 111,576

CURRENT ASSETS
Debtors 5 33,484 46,981
Cash at bank and in hand 1,621,960 1,403,217
1,655,444 1,450,198
CREDITORS
Amounts falling due within one year 6 132,435 179,226
NET CURRENT ASSETS 1,523,009 1,270,972
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,608,072

1,382,548

PROVISIONS FOR LIABILITIES 7 10,000 14,125
NET ASSETS 1,598,072 1,368,423

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 1,597,972 1,368,323
SHAREHOLDERS' FUNDS 1,598,072 1,368,423

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dr Memon Dermatology Services Limited (Registered number: 05024705)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 October 2025 and were signed on its behalf by:





A A Memon - Director


Dr Memon Dermatology Services Limited (Registered number: 05024705)

Notes to the Financial Statements
for the Year Ended 31 March 2025


1. STATUTORY INFORMATION

Dr Memon Dermatology Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Dr Memon Dermatology Services Limited (Registered number: 05024705)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4. TANGIBLE FIXED ASSETS
Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 April 2024 126,686 6,416 133,102
Additions - 2,473 2,473
Disposals - (1,799 ) (1,799 )
At 31 March 2025 126,686 7,090 133,776
DEPRECIATION
At 1 April 2024 18,347 3,179 21,526
Charge for year 27,085 1,498 28,583
Eliminated on disposal - (1,396 ) (1,396 )
At 31 March 2025 45,432 3,281 48,713
NET BOOK VALUE
At 31 March 2025 81,254 3,809 85,063
At 31 March 2024 108,339 3,237 111,576

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 26,783 45,643
Bad debt provision (3,611 ) (1,372 )
Directors' current accounts 7,338 -
Prepayments 2,974 2,710
33,484 46,981

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Corporation tax 121,712 123,683
Social security and other taxes 1,783 628
Directors' current accounts - 47,925
Accrued expenses 8,940 6,990
132,435 179,226

Dr Memon Dermatology Services Limited (Registered number: 05024705)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025


7. PROVISIONS FOR LIABILITIES
31.3.25 31.3.24
£    £   
Deferred tax 10,000 14,125

Deferred
tax
£   
Balance at 1 April 2024 14,125
Credit to Statement of Income and Retained Earnings during
year

(4,125

)
Balance at 31 March 2025 10,000

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.25 31.3.24
value: £    £   
80 A Ordinary £1 80 80
20 B Ordinary £1 20 20
100 100

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25 31.3.24
£    £   
A A Memon and J Memon
Balance outstanding at start of year - -
Amounts advanced 7,338 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 7,338 -

The loan was repaid on 6 April 2025

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is A A Memon.